Skip to main content
. 2024 Jun 3;5(1):iqae005. doi: 10.1093/oxfimm/iqae005

Table 2.

Clinical outcomes.

Characteristic n Overall, N = 90 Compensated DSS, N = 73 Decompensated DSSa, N = 17
Recurrent shock 90 16 (18) 10 (14) 6 (35)
 1 Episode 12 (13) 7 (10) 5 (29)
 2 Episodes 4 (4) 3 (4) 1 (6)
Respiratory distress 90 10 (11) 6 (8) 4 (24)
Profound shock 90 9 (10) 3 (4) 6 (35)
Percentage haemonconcentrationb, % 90 32 (25, 42) 32 (23, 39) 48 (31, 52)
Total IV fluid volume, ml/kg 90 130 (122, 149) 129 (121, 144) 133 (125, 175)
 Colloid, ml/kg 34 35 (35, 47) 35 (33, 43) 36 (35, 58)
 Crystalloid, ml/kg 90 123 (117, 134) 125 (118, 136) 95 (89, 118)
IV fluid duration, h 90 27.3 (24.9, 30.9) 27.2 (24.3, 30.2) 27.4 (27.0, 35.3)
Time to 1st re-shock, h 16 14 (11, 17) 14 (8, 16) 16 (13, 17)
Time to 2nd re-shock, h 4 25 (25, 26) 25 (25, 25) 29 (29, 29)
PICU duration, day 90 3 (3, 4) 3 (3, 4) 4 (3, 4)
Death 90 0 0 0
a

Decompensated DSS is defined as pulse pressure ≤ 10 mmHg or hypotension for age or unmeasurable blood pressure.

b

Percentage haemonconcentration was calculated as (enrolment– FU haematocrit/FU haematocrit) × 100.

Data are presented as absolute count (%) for categorical variables and median (IQR) for continuous data. N, number of patients; n, number of measurements; IV, intravenous; PICU, paediatric intensivecare unit.